The Antimicrobial Resistance Surveillance Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the Antimicrobial Resistance Surveillance has seen robust growth in recent years. The market size which was $6.77 billion in 2024 is projected to rise to $7.36 billion in 2025. This indicates a Compound Annual Growth Rate (CAGR) of 8.7%.
In 2029, the Antimicrobial Resistance Surveillance Global Market is projected to be worth $10.18 billion, growing at a compound annual growth rate (CAGR) of 8.5%.
Download Your Free Sample of the 2025 Antimicrobial Resistance Surveillance Market Report and Uncover Key Trends Now!The key drivers in the antimicrobial resistance surveillance market are:
• Growing awareness about antimicrobial resistance
• Advancements in diagnostic technologies
• Increasing government initiatives and funding
• Development of new antibiotics and alternatives
The antimicrobial resistance surveillance market covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
The key trends in the antimicrobial resistance surveillance market are:
• Artificial intelligence for data analysis is a major emerging trend in the antimicrobial resistance surveillance market.
• The adoption of next-generation sequencing technologies is another anticipated future trend.
• Real-time surveillance systems are also shaping the future of this market.
• The integration of big data and machine learning for predictive modeling is a notable emerging trend.
Major players in the antimicrobial resistance surveillance market are:
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Becton, Dickinson and Company
• Viatris Inc.
• Wolters Kluwer NV
• Hologic Inc.
• Biomerieux SA
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Qiagen NV
• Cepheid Inc.
• Shionogi & Co. Ltd.
• Venatorx Pharmaceuticals Inc.
• Accelerate Diagnostics Inc.
• Paratek Pharmaceuticals Inc.
• Liofilchem Srl
• Lumed Inc.
• OpGen Inc.
North America was the largest region in the antimicrobial resistance surveillance market in 2024